Publications by authors named "Irene Testi"

Claim this Profile
I
Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting.
Martino Pedrani, Giuseppe Salfi, Sara Merler, Irene Testi, Chiara Maria Agrippina Clerici

Int J Mol Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated review.
Giulia Claire Giudice, Michele Maffezzoli, Irene Testi, Alessandro Acunzo, Virginia Agnetti

Expert Rev Anticancer Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-related Hypertension as a Prognostic Factor for De Novo Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Real-world Evidence Study.
Giuseppe Salfi, Martino Pedrani, Selin Candan, Vasile Urechie, Sara Merler, Irene Testi

Eur Urol Open Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages.
Martino Pedrani, Jessica Barizzi, Giuseppe Salfi, Alessandro Nepote, Irene Testi

Int J Mol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis.
Martino Pedrani, Giuseppe Salfi, Sara Merler, Irene Testi, Massimiliano Cani

Eur Urol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapies and molecular targets in the therapeutic landscape of advanced urothelial carcinoma: state of the art and future perspectives.
Irene Testi, Giulia Claire Giudice, Giuseppe Salfi, Martino Pedrani, Sara Merler

Explor Target Antitumor Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors.
Giulia Mazzaschi, Fabiana Perrone, Giuseppe Maglietta, Elda Favari, Michela Verzè, Irene Testi

J Immunother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET alterations as resistance mechanisms of dabrafenib-trametinib in BRAF p.V600E mutated non-small cell lung cancer patient.
Monica Pluchino, Irene Testi, Roberta Minari, Alessandra Dodi, Giulia Airò

Anticancer Drugs· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Front-line Platinum Continues To Have a Role in Advanced Bladder Cancer.
Ursula M Vogl, Irene Testi, Maria De Santis

Eur Urol Focus· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies.
Chiara Tommasi, Giulia Airò, Fabiana Pratticò, Irene Testi, Matilde Corianò

J Clin Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
Melissa Bersanelli, Alessio Cortellini, Alessandro Leonetti, Alessandro Parisi, Marcello Tiseo, Irene Testi

Cancer Immunol Immunother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.
Giulia Mazzaschi, Giulia Claire Giudice, Matilde Corianò, Davide Campobasso, Fabiana Perrone, Irene Testi

Technol Cancer Res Treat· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis